USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -430.57 Thousand | -1.76 Million | -1.92 Million | -140.61 Thousand | -2.66 Million | -3.62 Million |
Net Income | -2.17 Million | -2.09 Million | 321.85 Thousand | -1.66 Million | -7.56 Million | -5.47 Million |
Depreciation & Amortization | 80.84 Thousand | 80.72 Thousand | 70.18 Thousand | 252.00 | 163.17 Thousand | 234.14 Thousand |
Deferred income taxes | 846.9 Thousand | 53.82 Thousand | -308.26 Thousand | - | -895.15 Thousand | -1.51 Million |
Stock-based compensation | 66.56 Thousand | 110.19 Thousand | 456.1 Thousand | - | 624.94 Thousand | 985.31 Thousand |
Change in working capital | 1.2 Million | 126.85 Thousand | 264.75 Thousand | 1.16 Million | 1.42 Million | 66.02 Thousand |
Other non-cash items | -463.1 Thousand | -33.91 Thousand | -2.73 Million | 355.41 Thousand | 3.57 Million | 2.07 Million |
Investing Cash Flow | -2498.00 | -7175.00 | -39.08 Thousand | - | -500 Thousand | -3 Million |
Investments in PPE | -2498.00 | -7175.00 | -1784.00 | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -2498.00 | -7175.00 | -37.29 Thousand | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 2498.00 | 7175.00 | -39.08 Thousand | - | -500 Thousand | -3 Million |
Financing Cash Flow | 434.37 Thousand | 798.95 Thousand | 2.97 Million | 136.8 Thousand | 2.54 Million | 7.14 Million |
Debt repayment | -114.01 Thousand | -82.5 Thousand | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 320.35 Thousand | 716.45 Thousand | 2.97 Million | 160.25 Thousand | 2.55 Million | 7.14 Million |
Other Financing Activities | 228.03 Thousand | 165 Thousand | 2.97 Million | -23.44 Thousand | -12.37 Thousand | 93.24 Thousand |
Accounts receivables | 14.55 Thousand | -8350.00 | -14.4 Thousand | -487.00 | 56.14 Thousand | -62.14 Thousand |
Accounts payables | 1.06 Million | 333.8 Thousand | 302.61 Thousand | - | 1.26 Million | 256.84 Thousand |
Inventory | - | - | - | - | -1.26 Million | -256.84 Thousand |
Other working capital | 133.28 Thousand | -198.6 Thousand | -23.46 Thousand | 1.16 Million | 1.36 Million | 128.16 Thousand |
Cash at beginning of period | 47.69 Thousand | 1.01 Million | 3171.00 | 6980.00 | 629.87 Thousand | 111.59 Thousand |
Cash at end of period | 48.92 Thousand | 47.69 Thousand | 1.01 Million | 3171.00 | 6980.00 | 629.87 Thousand |
Capital Expenditure | -2498.00 | -7175.00 | -1784.00 | - | - | - |
Effect of forex changes on cash | -64.00 | - | - | - | - | - |
Net cash flow / Change in cash | 1232.00 | -969.23 Thousand | 1.01 Million | -3809.00 | -622.89 Thousand | 518.27 Thousand |
Free Cash Flow | -433.07 Thousand | -1.76 Million | -1.92 Million | -140.61 Thousand | -2.66 Million | -3.62 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -324.97 Thousand | -308.03 Thousand | -452.9 Thousand | -2.17 Million | -823.2 Thousand | -328.4 Thousand |
Depreciation & Amortization | 135.00 | 132.00 | 135.00 | 80.84 Thousand | 20.2 Thousand | 20.21 Thousand |
Deferred income taxes | - | - | -175.34 Thousand | 846.9 Thousand | 315.84 Thousand | - |
Stock-based compensation | 75 Thousand | - | 175.34 Thousand | 66.56 Thousand | 49.27 Thousand | - |
Change in working capital | -1756.00 | 298.18 Thousand | 238.65 Thousand | 1.2 Million | 331.93 Thousand | 184.4 Thousand |
Other non-cash items | 235.16 Thousand | -12.21 Thousand | 176.33 Thousand | -463.1 Thousand | 58.63 Thousand | 9749.00 |
Investing Cash Flow | -2052.00 | -271.00 | - | -2498.00 | -1584.00 | - |
Investments in PPE | - | - | - | -2498.00 | -1498.00 | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -2052.00 | -271.00 | - | -2498.00 | -1498.00 | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -2052.00 | -271.00 | - | 2498.00 | 1412.00 | - |
Financing Cash Flow | 30.64 Thousand | 13.17 Thousand | -2500.00 | 434.37 Thousand | 56.2 Thousand | 70.31 Thousand |
Debt repayment | -32.00 | -823.00 | -2500.00 | -114.01 Thousand | -114.01 Thousand | -20.3 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -10.00 | - |
Common Stock Issuance | 30 Thousand | 14 Thousand | - | 320.35 Thousand | -10.00 | 50.01 Thousand |
Other Financing Activities | 30.67 Thousand | 14 Thousand | - | 228.03 Thousand | 170.23 Thousand | 40.6 Thousand |
Accounts receivables | -1756.00 | 1183.00 | -860.00 | 14.55 Thousand | 4246.00 | 36.52 Thousand |
Accounts payables | 226.55 Thousand | 298.84 Thousand | 145.67 Thousand | 1.06 Million | 401.28 Thousand | 151.88 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -1756.00 | -1840.00 | 93.83 Thousand | 133.28 Thousand | -73.6 Thousand | -4003.00 |
Cash at beginning of period | 987.00 | 6579.00 | 48.92 Thousand | 47.69 Thousand | 41.68 Thousand | 85.41 Thousand |
Cash at end of period | 9882.00 | 987.00 | 6579.00 | 48.92 Thousand | 48.92 Thousand | 41.68 Thousand |
Capital Expenditure | - | - | - | -2498.00 | -1498.00 | - |
Effect of forex changes on cash | -3267.00 | 3429.00 | -2070.00 | -64.00 | -64.00 | - |
Net cash flow / Change in cash | 8895.00 | -5592.00 | -42.35 Thousand | 1232.00 | 7247.00 | -43.72 Thousand |
Free Cash Flow | -16.43 Thousand | -21.92 Thousand | -37.78 Thousand | -433.07 Thousand | -48.81 Thousand | -114.03 Thousand |
DXYZ
0396
TRU
300056
BAFN
PHARMAID